International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) has been slipping to extremely cheap price levels in recent trade. That’s why today’s news could be such an important event for the long-term value of the shares of this company. It’s not often that we see such a clear catalyst.
Specifically, the company just announced a fully-executed partnership agreement with BioPulse Labs, a top nano-infusion and CBD branding name.
The Nuts and Bolts
The agreement stipulates that BioPulse will become the company’s exclusive manufacturing and marketing partner for the launch of five CBD-based wellness products, which will include a comprehensive branding refresh for the company’s P19 CBD-based products brand.
In addition, all of ISWH’s CBD products will be formulated and produced in FDA compliant and registered facilities, which is a clear differentiating factor given the prevalence of and increased regulatory attention aimed at CBD production that occurs in non-compliant “facilities” – ie, someone’s living room or backyard shed. So, this part of the agreement is clearly important.
Terry Williams, CEO of ISWH, commented, “BioPulse has the experience and capability to step in and help take our CBD-based products segment to a new level as we navigate this critical stage and transform enormous potential into accelerating revenue growth. This step will position our P19 brand as a differentiated product, both in terms of product quality through superior bioavailability and in terms of brand recognition, given BioPulse’s nationwide marketing and distribution footprint.
The deal, itself, maintains that BioPulse will provide ISWH with procurement of five trademarks, five brand custom websites (each with online sales and payment processing system), five brand social platforms (namely Facebook, Instagram, and Twitter), five brand POP, POS sales & marketing guides, five brand opening inventories, and continued marketing support following launch.
It was also stated that two of the five brands will feature compatible formulization and placement on Amazon.com.
This is huge news for a company that has started to breakthrough in its two other segments – home healthcare and top-shelf spirits. The agreement looks like it carries the potential to seriously ramp up the company’s commercial activity in its CBD segment, threatening to drive sales growth through the roof in coming quarters – something the market clearly hasn’t priced in at all.
Mr. Williams continued, “This is really an extraordinary partnership that will create a ton of value for our shareholders. The CBD market continues to exist in a context of high-powered growth. We believe the key to delivering that growth to our shareholders will be about differentiation and exposure. Simply having an ecommerce portal isn’t enough. The product has to be differentiated on a quality level and you have to get it in front of consumers. This partnership agreement delivers on both of those objectives.”
Given all of this, and given that ISWH shares are still sitting at rock-bottom bargain pricing, it may pay for investors to deal themselves a lotto ticket that looks to have much more interesting odds than you’re going to find at the 7-11. This is a real company with real operations that just signed a major partnership with one of the premier CBD product development and distribution players in the country.